While Pirfenidone exerts anti-fibrotic effects in IPF by enhancing Parkin-mediated mitophagy which inhibits PDGFR-PI3K-Akt axis and TGF-β-induced MFB activation (Kurita et al., 2017). This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.